Atara Biotherapeutics, Inc. (ATRA) Social Stream
Atara Biotherapeutics Inc (ATRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Atara Biotherapeutics Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 7 | $31 | $26 | $27.8 | $9.3 | 198.92% |
| 2021-12-09 | 7 | $31 | $26 | $28 | $9.3 | 201.08% |
| 2021-12-13 | 6 | $31 | $26 | $28 | $9.3 | 201.08% |
| 2021-12-15 | 5 | $31 | $24 | $27.25 | $9.3 | 193.01% |
| 2022-01-24 | 5 | $31 | $24 | $27.5 | $9.3 | 195.7% |
| 2022-01-26 | 5 | $31 | $25 | $27.75 | $9.3 | 198.39% |
| 2022-02-23 | 5 | $31 | $25 | $27 | $9.3 | 190.32% |
| 2022-03-01 | 5 | $31 | $20 | $25.75 | $9.3 | 176.88% |
The Trend in the Analyst Price Target
Over the past 178 days, ATRA's average price target has gone down $7.63.
ATRA reports an average of 126.24% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-17 | 6 | 78 | 10 | 35.57 | 13.28 | 167.85% |
| 2021-05-22 | 11 | 78 | 10 | 35.29 | 13.77 | 156.28% |
| 2021-08-14 | 11 | 78 | 10 | 35.00 | 12.45 | 181.12% |
| 2021-12-15 | 5 | 31 | 24 | 27.25 | 16.03 | 69.99% |
| 2022-01-14 | 5 | 31 | 24 | 27.50 | 16.07 | 71.13% |
ATRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 151 days, ATRA's average broker recommendation rating improved by 0.82.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATRA as an investment opportunity.
- Atara Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 789.24% of all US stocks.
- In the context of all US stocks, Atara Biotherapeutics Inc's variance in analysts' estimates is lower than -161.62% of them.
- In terms of how Atara Biotherapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 649.99% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Atara Biotherapeutics Inc's average analyst price target is higher than 562.28% of them.
Stocks similar to Atara Biotherapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATHA, APTO, and AMAM.
Is ATRA a Buy, Hold or Sell? See the POWR Ratings now!